These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2713644)

  • 21. Periaqueductal gray cholecystokinin infusions block morphine-induced disruption of maternal behavior.
    Miranda-Paiva CM; Canteras NS; Sukikara MH; Nasello AG; Mackowiak II; Felicio LF
    Peptides; 2007 Mar; 28(3):657-62. PubMed ID: 17194502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cholecystokinin octapeptide and ceruletide on release of acetylcholine from cerebral cortex of the rat in vivo.
    Magnani M; Mantovani P; Pepeu G
    Neuropharmacology; 1984 Nov; 23(11):1305-9. PubMed ID: 6098846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G; Hsiao S; Itoh S
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of cholecystokinin in the opioid tolerance induced by dipyrone (metamizol) microinjections into the periaqueductal gray matter of rats.
    Tortorici V; Nogueira L; Aponte Y; Vanegas H
    Pain; 2004 Nov; 112(1-2):113-20. PubMed ID: 15494191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the analgesia inhibitory system by D-phenylalanine and proglumide.
    Takeshige C; Mera H; Hisamitsu T; Tanaka M; Hishida F
    Brain Res Bull; 1991 Mar; 26(3):385-91. PubMed ID: 2049604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphine-induced increases of extracellular histamine levels in the periaqueductal grey in vivo: a microdialysis study.
    Barke KE; Hough LB
    Brain Res; 1992 Feb; 572(1-2):146-53. PubMed ID: 1611509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Science; 1984 Apr; 224(4647):395-6. PubMed ID: 6546809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antagonism to morphine analgesia and involvement in morphine tolerance of angiotensin II in periaqueductal gray of the rabbits].
    Wang XM; Han JS
    Zhongguo Yao Li Xue Bao; 1989 Jul; 10(4):294-7. PubMed ID: 2624110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex Differences in Microglia Activity within the Periaqueductal Gray of the Rat: A Potential Mechanism Driving the Dimorphic Effects of Morphine.
    Doyle HH; Eidson LN; Sinkiewicz DM; Murphy AZ
    J Neurosci; 2017 Mar; 37(12):3202-3214. PubMed ID: 28219988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat. I. The production of behavioral side effects together with analgesia.
    Fardin V; Oliveras JL; Besson JM
    Brain Res; 1984 Jul; 306(1-2):105-23. PubMed ID: 6540613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Periaqueductal gray matter stimulation-produced analgesia in diabetic rats.
    Kamei J; Aoki T; Kasuya Y
    Neurosci Lett; 1992 Aug; 142(1):13-6. PubMed ID: 1407710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proglumide prevents and curtails acute tolerance to morphine in rats.
    Tang J; Chou J; Iadarola M; Yang HY; Costa E
    Neuropharmacology; 1984 Jun; 23(6):715-8. PubMed ID: 6462377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the antinociceptive effect of morphine and glutamate at coincidental sites in the periaqueductal gray and medial medulla in rats.
    Jensen TS; Yaksh TL
    Brain Res; 1989 Jan; 476(1):1-9. PubMed ID: 2563331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholecystokinin octapeptide (CCK-8): antagonism to electroacupuncture analgesia and a possible role in electroacupuncture tolerance.
    Han JS; Ding XZ; Fan SG
    Pain; 1986 Oct; 27(1):101-115. PubMed ID: 3491355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog.
    Inui A; Inoue T; Sakatani N; Oya M; Morioka H; Baba S
    Brain Res; 1987 Aug; 417(2):355-9. PubMed ID: 3651819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of beta-endorphin effects by proglumide in rats.
    Katsuura G; Itoh S
    Eur J Pharmacol; 1985 Jan; 107(3):363-6. PubMed ID: 3156751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in stimulation analgesia during chronic morphine administration].
    Morozova AS; Zvartau EE
    Farmakol Toksikol; 1985; 48(4):61-4. PubMed ID: 4043366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus.
    Bodnar RJ; Paul D; Rosenblum M; Liu L; Pasternak GW
    Brain Res; 1990 Oct; 529(1-2):324-8. PubMed ID: 2282501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates?
    Han JS; Ding XZ; Fan SG
    Neuropeptides; 1985 Feb; 5(4-6):399-402. PubMed ID: 4000412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analgesia from the periaqueductal gray in the developing rat: focal injections of morphine or glutamate and effects of intrathecal injection of methysergide or phentolamine.
    Tive LA; Barr GA
    Brain Res; 1992 Jul; 584(1-2):92-109. PubMed ID: 1355395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.